Navigation Links
Benaroya Research Institute announces $4.4 million grant for type 1 diabetes
Date:2/14/2013

(Seattle, Feb.14, 2013) In a major effort to advance discoveries in type 1 diabetes research, the Benaroya Research Institute at Virginia Mason (BRI) established the T1D Exchange Biobank Operations Center with a $4.4 million grant from The Leona M. and Harry B. Helmsley Charitable Trust. The T1D Exchange Biobank Operations Center led by Carla Greenbaum, MD, Director of the Diabetes Research Program at BRI, will coordinate clinical study proposals and sample requests including protocol design, sample procurement and distribution.

Dr. Greenbaum serves on the Joint Steering Committee for the T1D Exchange which offers a comprehensive view of type 1 diabetes including clinical and academic research, real-world data, clinically-annotated biosamples, and patient insights. The T1D Exchange consists of a Clinic Network with access to more than 100,000 patients, a Clinic Registry with over 26,000 well-characterized patients, the online community Glu, and the Biorepository whose goal it is to distribute, share and exchange meaningful data and biosamples to drive collaboration and disseminate knowledge across the type 1 diabetes (T1D) community.

"We are thrilled to see the establishment of the T1D Exchange Biobank Operations Center as a key factor in advancing the mission of T1D Exchange to speed better treatments, therapies and research. Giving biological samples is one way people touched by type 1 diabetes are empowered to contribute to improved outcomes on the path to a cure. We have a strong, productive working relationship with Dr. Carla Greenbaum and her team at the Benaroya Research Institute and are eager to see this collaboration yield data that will be impactful to the type 1 diabetes community," shared Dana Ball, CEO and Cofounder of the T1D Exchange.

BRI was selected to receive this grant to establish the T1D Exchange Biobank Operations Center by the Helmsley Charitable Trust because of the organization's reputation in autoimmune diseases research with a focus in type 1 diabetes and biobanking. Under the direction of Dr. Greenbaum, BRI has created one of the world's most robust biobanks for the study of autoimmune disorders dating back to the year 2000. BRI actively maintains biobanks for eleven different autoimmune diseases. BRI also maintains a registry of healthy people for comparison purposes.

"BRI has a long track record of developing and maintaining biobanks which have led directly to the advancement of understanding autoimmune diseases, including type 1 diabetes. We are excited to be in on the ground floor of an initiative that will have enormous impact on the type 1 diabetes community by helping to facilitate research with a large numbers of participants. This work will accelerate our understanding, hopefully leading to a cure for this disease," notes Dr. Greenbaum.

"We are pleased to support this important initiative, which is in keeping with our strategy of filling gaps and creating tools that help the entire T1D community," said David Panzirer, a Trustee of the Helmsley Charitable Trust.


'/>"/>
Contact: Kay Branz
kbranz@benaroyaresearch.org
206-342-6503
Immune Tolerance Network
Source:Eurekalert

Related medicine news :

1. Plasticizers Market - New Industry Research Report is Now Available for Pre Order at Transparency Market Research
2. UNC researchers discover gene that suppresses herpesviruses
3. Researchers discover biological diversity in triple-negative breast cancer
4. Additional noteworthy research to be presented at the 2013 Genitourinary Cancers Symposium
5. Lifespan research program earns national recognition
6. MIND Institute researchers receive $1 million grant to study cognitive training in fragile X
7. Refinery Catalyst Market - New Industry Research Report is Now Available for Pre Order at Transparency Market Research
8. Research from the 2013 Genitourinary Cancers Symposium highlights new insights on high-risk prostate cancer prevalence and treatment, compares benefit of surveillance and surgery for management of small kidney tumors
9. Breast Cancer Research Needs More Focus on Environment: Report
10. UCIs Gavin Herbert Eye Institute receives $3 million for retinal degeneration research
11. Effective treatment for late infantile batten disease developed by MU, BioMarin researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... Nashville, Tennessee (PRWEB) , ... August 23, 2017 ... ... expand its team to support long-term strategic growth plans, announcing the hiring of ... , A certified technology consultant and seasoned sales manager, Keelan will be working ...
(Date:8/23/2017)... ... August 23, 2017 , ... A new literature ... Surgeons , points out that therapeutic modalities (physical therapy) is an important part ... the report, a wider scope of physical therapy options is showing promising results ...
(Date:8/22/2017)... FRANCISCO BAY AREA, CA (PRWEB) , ... August ... ... premier, Nuvesse, an accessible luxurious collection of unique masks and serums that perfectly ... in scientific skin care advancements, at the 2017 Indie Beauty Expo on August ...
(Date:8/22/2017)... ... August 22, 2017 , ... The old ... is as simple as eating healthy foods. But this well-known piece of nutrition ... insulin, or breaking apart carbohydrates—depends not only on properties of the food but ...
(Date:8/22/2017)... ... August 22, 2017 , ... Pivot Point ... of Zack Tisch as the firm’s new Consulting Services Executive. Mr. Tisch will ... national accounts, from assisting clients with initial vendor selection and pre-implementation planning through ...
Breaking Medicine News(10 mins):
(Date:7/31/2017)... 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), has been named ... by Crain,s Detroit Business . ... by three-year revenue growth. This year,s edition measures growth from ... view the complete list, visit crainsdetroit.com/awards/fast_50/2017 .  ... triumph," said Phil Hagerman , CEO and chairman of ...
(Date:7/28/2017)... EnvoyHealth, a Diplomat company, has partnered with Compliance ... LITE, a technology designed to improve patient medication adherence. ... technology solutions and services that help track and improve ... CleverCap LITE offers medication monitoring and control for patients ... Records date and time of ...
(Date:7/26/2017)... a leading medical aesthetic clinic in Singapore ... conditions from the inside. The natural process of aging ... becomes more transparent due to the thinning of the epidermis. Over the ... sun contributes to aging skin, causing age spots and other types ... ...
Breaking Medicine Technology: